MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-02-0030754
Gladstone Pharma India Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹47.93 Cr
▲ 27% YoY
Net profit · FY 2024
₹96.56 Lakh
Net margin 2%
EBITDA · FY 2024
₹1.79 Cr
EBITDA margin 3.7%
Authorised capital
₹2.5 Cr
Registered with MCA
Paid-up capital
₹2.5 Cr
Issued & subscribed
Open charges
₹2.3 Cr
Satisfied ₹1.2 Cr
Company age
15 yrs
Est. 2011
Employees · EPFO
228
Provident fund records
About Gladstone Pharma India Private Limited
Data last updated:
Gladstone Pharma India Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 November 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24100TN2011PTC082948. Its GSTIN is 33AAECG4553H1ZR (Tamil Nadu).
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.5 Cr. It is led by directors including Pichai Chandrasekaran (Managing Director) and Hariharan Ramesh.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.274 Flat D Pearl Flat Nateshnagar 2nd Cross Street Virugambakkam, Chennai, Tamil Nadu, India – 600092.
As per the financials filed for FY 2024, the company reported a revenue of ₹47.93 Cr, a growth of 27% compared to the previous year. For the same year it recorded a net profit of ₹96.56 Lakh (net margin 2%) and EBITDA of ₹1.79 Cr (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 47% over three years and 18% over five years.
The company has about 228 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Gladstone Pharma. As per MCA filings, the company has open charges of ₹2.3 Cr and satisfied charges of ₹1.2 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending. The company has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹1.19 Cr; the latest was in March 2019. Its 7 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 4 larger and 3 smaller; the largest is Sundarlal Pharma Distributors Private Limited with revenue of ₹48.84 Cr. The company has 6 MSME Form 1 returns on record between 2019 and 2023, listing 308 overdue payments to 11 micro and small suppliers.
Gladstone Pharma India Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0030754). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gladstonepharma.com.
Company details
CIN U24100TN2011PTC082948
Registration Number 082948
Incorporation Date 01 November 2011
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 24 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-02-0030754
Key People
Pichai Chandrasekaran Managing Director Hariharan Ramesh Director Shanmugam Santhosh Director Recognitions & Rankings of Gladstone Pharma India
Contact details
Gladstone Pharma India Private Limited's registered office is in Chennai, Tamil Nadu. Its website is gladstonepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.274 Flat D Pearl Flat Nateshnagar 2nd Cross Street Virugambakkam, Chennai, Tamil Nadu, India – 600092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Gladstone Pharma India Private Limited, buy the company report.
Comprehensive company report
Gladstone Pharma India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Gladstone Pharma India operates one associated brand: Gladstone Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and therapy development in India. | gladstonepharma.com |
Business activity
The main business activity of Gladstone Pharma India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Gladstone Pharma India Private Limited, buy the company report.
Financials of Gladstone Pharma India Private Limited
FY 2025 filings availableGladstone Pharma India Private Limited reported revenue of ₹47.93 Cr (up 27% YoY) for FY 2024.
Revenue · FY 2024
₹47.93 Cr ▲ 27%
Net profit · FY 2024
₹96.56 Lakh margin 2%
EBITDA · FY 2024
₹1.79 Cr margin 3.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 27%
3 years · compounded
▲ 47%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 42%
3 years · compounded
▲ 36%
5 years · compounded
▲ 16%
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 27% growth in the latest year. EBITDA rose 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.79 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹96.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gladstone Pharma India Private Limited, buy the company report.
Board of directors of Gladstone Pharma India Private Limited
Gladstone Pharma India has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hariharan Ramesh | Director | 02 Mar 2017 | 9 Years 7 Months | Current |
| Pichai Chandrasekaran | Managing Director | 01 Nov 2011 | 14 Years 11 Months | Current |
| Shanmugam Santhosh | Director | 01 Nov 2011 | 14 Years 11 Months | Current |
| Ariyalur Suryanarayanan Ramasamy | Director | 24 Sep 2016 | 10 Years 1 Months | Current |
Peer comparison
Gladstone Pharma India Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sundarlal Pharma Distributors Private Limited | ₹48.84 Cr (FY 2025) | 24.0% | Mumbai, Maharashtra, India | |||
| Welcomevet Pharma Private Limited | ₹48.7 Cr (FY 2025) | 4.0% | Lucnow, Uttar Pradesh, India | |||
| Shah Medico Private Limited | ₹48.25 Cr (FY 2025) | 39.0% | Pune, Maharashtra, India | |||
| Fresh Focus Consumer Products Private Limited | ₹48.02 Cr (FY 2025) | -6.0% | Kolkata, West Bengal, India | |||
| Gladstone Pharma India Private Limitedthis company | ₹47.93 Cr (FY 2024) | ₹96.56 Lakh | 2% | 27.0% | 228 | Chennai, Tamil Nadu, India |
| Kothiwal Healthcare Private Limited | ₹47.77 Cr (FY 2025) | -17.0% | Uttar Pradesh, India | |||
| Leo Pharma Distributors Private Limited | ₹47.6 Cr (FY 2024) | -43.0% | Thrissur, Kerala, India | |||
| Hemavati Traders Private Limited | ₹47.42 Cr (FY 2025) | 12.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Gladstone Pharma India Private Limited, buy the company report.
Auditor
Gladstone Pharma India Private Limited is audited by Gopal Selvin and Parasar for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Gopal Selvin and Parasar | FY 2023 | 012672S |
Shareholding
The shareholding of Gladstone Pharma India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Gladstone Pharma India Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.3 Cr
Satisfied charges
₹1.2 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jan 2020 | 100322992 | Others | ₹2.3 Cr | Open | |
| 29 Nov 2018 | 100231972 | Others | ₹1.2 Cr | Satisfied |
To see the full charge records of Gladstone Pharma India Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Gladstone Pharma India Private Limited has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹1.19 Cr; the latest was in March 2019.
Total deals
3
Funding rounds
2
Rights issue
1
Disclosed funding
₹1.19 Cr
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Funding round | ₹78.5 Lakh | Investors: 3 individuals |
| Mar 2017 | Funding round | ₹40 Lakh | Investors: 4 individuals |
| Apr 2015 | Rights issue | ₹9 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Gladstone Pharma India Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thanjavur, Tamil Nadu | Criminal miscellaneous application | Filed against the company by Drugs Inspector, Union of India | Pending |
To see the full case history of Gladstone Pharma India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Gladstone Pharma India Private Limited has 6 MSME Form 1 returns on record between 2019 and 2023, listing 308 overdue payments to 11 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 11)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| JS Laboratories | |||
| Ethix Healthcare | |||
| Elista Pharmaceuticals | |||
| Ceego Labs Private Limited | |||
| Pharma Fabrikon |
To see the full MSME payment records of Gladstone Pharma India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Gladstone Pharma India Private Limited has a workforce of 228 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
228
Active EPFO establishments
1
Employee growth
23.24%
GST
Gladstone Pharma India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAECG4553H1ZR | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Gladstone Pharma India Private Limited, buy the company report.
Recent activity
Gladstone Pharma India Private Limited has 9 board changes on record since 2011: 4 appointments and 5 cessations. The latest: Murali Venkatachalam ceased to be Director on 28 Aug 2019.
AGM
Gladstone Pharma India Private Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records.
Filing
Gladstone Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Others of Rs. 2.30 Cr registered on 30 Jan 2020 with Charge ID 100322992 was modified on 27 Oct 2020.
Charges
A charge registered on 29 Nov 2018 via Charge ID 100231972 with Others was fully satisfied on 11 Mar 2020.
Charges
A charge with Others amounted to Rs. 2.30 Cr with Charge ID 100322992 was registered on 30 Jan 2020.
Ceased
Murali Venkatachalam ceased to be Director.
Charges
A charge with Others amounted to Rs. 1.20 Cr with Charge ID 100231972 was registered on 29 Nov 2018.
Ceased
Meenakshi ceased to be Director.
Ceased
Dhanasekar ceased to be Director.
Appointed
Hariharan Ramesh was appointed as Director.
Ceased
Ariyalur Suryanarayanan Ramasamy ceased to be Additional Director.
Appointed
Ariyalur Suryanarayanan Ramasamy was appointed as Director.
4 earlier events are in the company report.
Frequently asked questions
Gladstone Pharma India is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 November 2011 (15+ years old) and is registered under CIN U24100TN2011PTC082948.
Gladstone Pharma India has 4 current directors:
- Pichai Chandrasekaran - Managing Director
- Hariharan Ramesh - Director
- Shanmugam Santhosh - Director
- Ariyalur Suryanarayanan Ramasamy - Director
The latest financial statements of Gladstone Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Gladstone Pharma India is 33AAECG4553H1ZR, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Gladstone Pharma India is U24100TN2011PTC082948. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gladstone Pharma India has 1 court case on record: 1 filed against it. 1 is pending.
Gladstone Pharma India was incorporated on 01 November 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chennai.
Gladstone Pharma India has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹1.19 Cr; the latest was in March 2019.
The peers of Gladstone Pharma India by revenue are Sundarlal Pharma Distributors Private Limited, Welcomevet Pharma Private Limited, Shah Medico Private Limited, Fresh Focus Consumer Products Private Limited, Kothiwal Healthcare Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Murali Venkatachalam ceased to be Director on 28 Aug 2019. Meenakshi ceased to be Director on 31 Oct 2018. Dhanasekar ceased to be Director on 28 Sep 2017. Gladstone Pharma India has 9 board changes on record in total.
Yes, Gladstone Pharma India is registered as a small enterprise under Udyam registration (number: UDYAM-TN-02-0030754).
Gladstone Pharma India has 6 MSME Form 1 returns on record between 2019 and 2023, listing 308 overdue payments to 11 micro and small suppliers. The latest return was filed on 27 Aug 2023.